ILLUMINA, INC NEXTSEQ 2000 SEQUENCER REAGENT KIT.
SAM.GOV Due: May 23, 2025 at 04:00 PM UTC
In-Active Presolicitation Source Url

Summary

The opportunity involves the procurement of the Illumina, Inc NextSeq 2000 Sequencer Reagent Kit, which is intended for use by the National Institutes of Health (NIH) Clinical Center's Center for Cellular Engineering (CCE). This presolicitation notice indicates that the NIH intends to award a sole source contract to Illumina, Inc for these specific reagent kits, which are essential for ongoing studies involving RNA sequencing and other genomic analyses. The kits are noted for their high-throughput capabilities and compatibility with the NextSeq 2000 sequencer, making them critical for the lab's operations. Only Illumina, Inc is capable of providing these kits due to their unique manufacturing processes and regulatory compliance, which would be costly and time-consuming to replicate with another vendor. Therefore, businesses that specialize in in vitro diagnostic substances and have the necessary manufacturing capabilities should consider this opportunity, although it is primarily directed towards Illumina, Inc.
Description

NOTICE OF INTENT: ILLUMINA, INC NEXTSEQ 2000 SEQUENCER REAGENT KIT.

  • Product Service Code: 6550- In Vitro Diagnostic Substances, Reagents, Test Kits and Sets
  • NAICS Code: 325413 - In Vitro Diagnost
Entities
HAHSDO
Department of Health and Human Services
NIOH
National Institutes of Health
NAICS
325413
Set Aside
None
Place of Performance
Bethesda , Maryland 20892
Point of Contact
Full Name Email Phone Type
Emeka Onyejekwe [email protected] 0000000000 primary